# LRRK2 (Leucine-Rich Repeat Kinase 2) Parkinson's Disease Fingerprint

> **NCT07681219** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 20 (estimated)

## Conditions studied

- Parkinsons Disease (PD)
- LRRK2

## Interventions

- **DIAGNOSTIC_TEST:** The interventions of the study are the study of blood biomarkers and neuroimaging and neurophysiological data

## Key facts

- **NCT ID:** NCT07681219
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681219, "LRRK2 (Leucine-Rich Repeat Kinase 2) Parkinson's Disease Fingerprint". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*